KRAS and colorectal carcinoma: The crucial role of the mitochondrial glutamate carrier in cytosolic availability of the glutamine-derived aspartate in KRAS-mutated CRC cells was further supported by the rescue of the proliferation defect induced by SLC25A22 knockdown via the addition of aspartate in the growth medium.